Huapont Life Sciences Co Ltd Financial Flexibility Index
Huapont Life Sciences Co Ltd financial flexibility index. Huapont Life Sciences Co Ltd (002004) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥795.22 Million (operating CF CN¥635.17 Million minus capex CN¥160.05 Million) represents 0% of total liabilities (CN¥13.15 Billion). See free cash flow generation of Huapont Life Sciences Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Huapont Life Sciences Co Ltd (2002–2025)
Financial flexibility index of Huapont Life Sciences Co Ltd from 2002 to 2025. Historical Financial Flexibility Index trend for Huapont Life Sciences Co Ltd across 24 annual periods. Check Huapont Life Sciences Co Ltd (002004) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Huapont Life Sciences Co Ltd Financial Flexibility Index by Year (2002–2025)
Huapont Life Sciences Co Ltd financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for Huapont Life Sciences Co Ltd. For the full cash flow conversion analysis, see 002004 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥2.73 Billion | CN¥2.10 Billion | CN¥12.05 Billion | ▲ +22.9% |
| 2024 | 0.18x | CN¥2.58 Billion | CN¥1.63 Billion | CN¥13.98 Billion | ▼ -9.1% |
| 2023 | 0.20x | CN¥2.87 Billion | CN¥1.59 Billion | CN¥14.14 Billion | ▼ -22.6% |
| 2022 | 0.26x | CN¥3.54 Billion | CN¥2.41 Billion | CN¥13.47 Billion | ▲ +47.9% |
| 2021 | 0.18x | CN¥2.53 Billion | CN¥1.27 Billion | CN¥14.22 Billion | ▼ -30.6% |
| 2020 | 0.26x | CN¥3.60 Billion | CN¥2.37 Billion | CN¥14.09 Billion | ▼ -2.6% |
| 2019 | 0.26x | CN¥3.52 Billion | CN¥2.08 Billion | CN¥13.39 Billion | ▲ +20.4% |
| 2018 | 0.22x | CN¥3.01 Billion | CN¥1.91 Billion | CN¥13.80 Billion | ▲ +120.1% |
| 2017 | 0.10x | CN¥1.56 Billion | CN¥591.40 Million | CN¥15.79 Billion | ▲ +15.1% |
| 2016 | 0.09x | CN¥1.16 Billion | CN¥511.90 Million | CN¥13.52 Billion | ▼ -31.9% |
| 2015 | 0.13x | CN¥1.17 Billion | CN¥342.45 Million | CN¥9.30 Billion | ▼ -5.0% |
| 2014 | 0.13x | CN¥1.04 Billion | CN¥455.96 Million | CN¥7.84 Billion | ▼ -33.8% |
| 2013 | 0.20x | CN¥729.31 Million | CN¥349.51 Million | CN¥3.64 Billion | ▲ +3.8% |
| 2012 | 0.19x | CN¥572.96 Million | CN¥257.75 Million | CN¥2.97 Billion | ▲ +34.1% |
| 2011 | 0.14x | CN¥230.99 Million | CN¥135.23 Million | CN¥1.60 Billion | ▼ -66.0% |
| 2010 | 0.42x | CN¥136.71 Million | CN¥79.84 Million | CN¥322.58 Million | ▼ -47.1% |
| 2009 | 0.80x | CN¥196.99 Million | CN¥123.53 Million | CN¥245.68 Million | ▲ +26.4% |
| 2008 | 0.63x | CN¥206.25 Million | CN¥113.76 Million | CN¥325.26 Million | ▲ +11.6% |
| 2007 | 0.57x | CN¥203.23 Million | CN¥79.21 Million | CN¥357.78 Million | ▲ +20.8% |
| 2006 | 0.47x | CN¥113.87 Million | CN¥66.10 Million | CN¥242.18 Million | ▼ -80.2% |
| 2005 | 2.37x | CN¥88.12 Million | CN¥43.69 Million | CN¥37.17 Million | ▲ +93.2% |
| 2004 | 1.23x | CN¥97.43 Million | CN¥70.60 Million | CN¥79.39 Million | ▲ +12.2% |
| 2003 | 1.09x | CN¥87.50 Million | CN¥56.68 Million | CN¥79.99 Million | ▲ +28.1% |
| 2002 | 0.85x | CN¥89.59 Million | CN¥36.88 Million | CN¥104.91 Million | — |